Latest News Israel

Israeli Crowdfunding Co. OurCrowd Raises $72M

Share |
Friday, September 23rd, 2016

The Jerusalem-based crowdfunding platform has to date invested over $300 million in 100 portfolio companies and funds.

As reported in Globes:

Israeli global equity crowdfunding platform OurCrowd has closed $72 million in Series C funding. Participants in this latest round include financial institutions, family offices, and private investors from five continents.

OurCrowd CEO Jon Medved said, “OurCrowd has grown exponentially since our launch in 2013 to become the leading global platform for Equity Crowdfunding. This transformative Series C funding will allow us to take advantage of the growing investor interest in quality equity crowdfunding and further expand our global operations. One half of the round will be invested in the expansion of our 7 global offices, and further developing our technology platform. The other half of the Series C funding will be used to make sure that each and every company which raises funding on our platform receives participating investment from the General Partner on the same terms as the crowd. This new capital will help us hit our goal of investing $1 billion annually by 2020.”

OurCrowd has had nine exits to date from its portfolio investments: two IPO’s and seven acquisitions. These include ReWalk (IPO: Nasdaq), Crosswise (bought by Oracle), Replay Technologies (bought by Intel), and NextPeer (bought by Viber).

Geoff Levy, Chairman of Monash Private Equity in Sydney, Australia, an OurCrowd investor and member of the OurCrowd Advisory Board, stated that “OurCrowd has grown incredibly fast over the last 3+ years. With this new and important Series C funding, we expect to continue this steep growth trajectory, not only gaining more investors and capital worldwide, but most importantly increasing the ‘crowds’ involvement in sourcing and adding value to our remarkable portfolio of companies.”

OurCrowd CEO Jon Medved will be speaking at the The BRIDGE: Israel-Australia Investment Summit, which will take place in Sydney on the 8th-9th of November.